Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial Post author:Sam Post published:February 5, 2018 Post category:BioPharma The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace You Might Also Like Celsion To Hold First Quarter 2017 Financial Results Conference Call On Friday, May 12, 2017 May 4, 2017 Boehringer Ingelheim, Roche Forge Partnership for Inflammatory Bowel Diseases December 18, 2017 Merrimack Pharmaceuticals Expands Phase II Lung Cancer Study March 11, 2018
Celsion To Hold First Quarter 2017 Financial Results Conference Call On Friday, May 12, 2017 May 4, 2017
